Filing Details
- Accession Number:
- 0001567619-21-021857
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-09 17:47:43
- Reporting Period:
- 2021-12-07
- Accepted Time:
- 2021-12-09 17:47:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1770787 | 10X Genomics Inc. | TXG | Laboratory Analytical Instruments (3826) | 455614458 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1786720 | Serge Saxonov | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-12-07 | 5,209 | $5.04 | 889,818 | No | 4 | M | Direct | |
Class A Common Stock | Acquisiton | 2021-12-07 | 3,037 | $11.48 | 892,855 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2021-12-07 | 200 | $138.86 | 892,655 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-12-07 | 766 | $142.40 | 891,889 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-12-07 | 3,187 | $143.36 | 888,702 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-12-07 | 672 | $144.27 | 888,030 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-12-07 | 571 | $145.79 | 887,459 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-12-07 | 6,480 | $147.05 | 880,979 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-12-07 | 2,370 | $147.96 | 878,609 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-12-07 | 754 | $148.60 | 877,855 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (right to buy) | Disposition | 2021-12-07 | 5,209 | $0.00 | 5,209 | $5.04 |
Class A Common Stock | Stock Option (right to buy) | Disposition | 2021-12-07 | 3,037 | $0.00 | 3,037 | $11.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
53,323 | 2028-11-02 | No | 4 | M | Direct | |
48,596 | 2029-05-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 4,498 | Indirect | See footnote |
Class A Common Stock | 89,960 | Indirect | See footnote |
Footnotes
- The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $141.77 to $142.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $142.86 to $143.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $144.00 to $144.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $145.34 to $146.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $146.45 to $147.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $147.4621 to $148.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $148.545 to $148.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- This option, originally for 250,000 shares, of which 196,677 have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
- This option, originally for 145,786 shares, of which 97,190 have been exercised, vested as to 1/48th of the shares on May 1, 2019, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.